Where to Buy NAD+: A Complete Buying Guide for the Longevity Research Compound

NAD+ stands for nicotinamide adenine dinucleotide, and it is one of the most fundamental molecules in living cells. It acts as a coenzyme in hundreds of metabolic reactions, shuttling electrons during the process that converts food into usable cellular energy (ATP). Without adequate NAD+, mitochondria cannot efficiently power the cell, which is why the molecule has become a focal point for researchers studying energy metabolism and aging.

Beyond its role in energy production, NAD+ is a required substrate for several families of enzymes involved in cellular maintenance. These include the sirtuins, which are linked to DNA repair and metabolic regulation, and the PARP enzymes, which respond to DNA damage. Because these repair systems consume NAD+, the availability of the molecule directly influences how well cells can maintain their own genomes over time.

The longevity interest stems from a consistent observation across multiple species: tissue NAD+ levels decline with age. Researchers have documented lower NAD+ concentrations in older animals and humans, and this decline correlates with reduced mitochondrial function and impaired repair capacity. The central hypothesis under investigation is whether restoring NAD+ toward youthful levels can support cellular resilience.

It is important to frame this accurately. NAD+ is a well-characterized biochemical, and its decline with age is documented, but the idea that supplementing it slows human aging remains a research hypothesis, not an established medical fact. Much of the most striking data comes from preclinical models rather than large human trials. This guide focuses on how the compound is sold and how to evaluate quality, not on any therapeutic claim.

For readers new to this space, our overview of what peptides and related research compounds are provides useful context on how these molecules are classified and studied.

Despite frequently appearing in peptide catalogs and being searched for as the "NAD+ peptide," the honest scientific answer is that NAD+ is not a peptide. A peptide is a short chain of amino acids linked by peptide bonds. NAD+ contains no amino acids and no peptide bonds. It is a dinucleotide, formed from two nucleotides joined through their phosphate groups: one built around adenine and one around nicotinamide.

Its molecular formula is C₂₁H₂₇N₇O₁₄P₂, with a molecular weight of approximately 663.43 g/mol. Structurally, it belongs to the same broad chemical family as ATP and other nucleotide coenzymes, not to the peptide family that includes compounds like GHK-Cu or BPC-157.

So why is it grouped with peptides commercially? Vendors that specialize in research compounds tend to carry a mixed catalog of peptides, nucleotides, and other injectable research chemicals under one umbrella. Because NAD+ is often reconstituted and handled in the same way as lyophilized peptides, and because the longevity community discusses it alongside peptides, it has inherited the informal "peptide" label in search behavior and marketing. That label is imprecise but widespread.

Understanding this distinction matters for buyers. It affects how you interpret a certificate of analysis: purity assays and identity confirmation for a nucleotide coenzyme rely on techniques such as HPLC and mass spectrometry, just as they do for peptides, but the expected impurity profile and degradation products differ. Knowing you are buying a dinucleotide, not a short amino-acid chain, helps you ask the right questions of a supplier.

When you see "NAD+ peptide" advertised, read it as shorthand for "NAD+ research compound sold through a peptide vendor," and evaluate it on the quality signals described below rather than on the label itself.

Because research compounds are not manufactured to pharmaceutical standards by default, the burden falls on the buyer to verify quality. Four criteria carry the most weight, and each should be verifiable rather than simply claimed on a product page.

1. Stated purity. Look for a documented purity of 99% or higher. Purity refers to how much of the material is genuinely NAD+ versus residual solvents, salts, or degradation byproducts. A vendor that publishes a specific figure backed by an assay is more credible than one that states "high purity" with no number.

2. A recent certificate of analysis (COA). The COA is the single most important document. It should be batch-specific, dated, and show the analytical methods used, typically HPLC for purity and mass spectrometry for identity confirmation. A generic COA reused across every batch, or one with no batch number, is a warning sign.

3. Independent third-party testing. The strongest signal is a COA from an accredited laboratory that is independent of the seller. In-house testing can be legitimate, but third-party verification removes the conflict of interest. Some vendors publish both the manufacturer COA and an independent lab report; that is the gold standard.

4. Professional presentation. Research-grade NAD+ is normally supplied as a lyophilized (freeze-dried) powder in a sealed, sterile vial with a clear label stating the compound, mass, and batch. Amber or protective vials, tamper-evident seals, and correct cold-chain or storage guidance all indicate a supplier that understands the material's sensitivity to heat, light, and moisture.

The table below summarizes what to look for and what should give you pause.

If a vendor cannot produce a current COA on request, treat that as disqualifying regardless of price.

Sourcing NAD+ responsibly means choosing vendors that publish documentation and ship legally to your region. Two established international suppliers illustrate the range of options, each serving a different market.

AminoClub is a US-focused vendor that ships within the United States and carries a narrow, longevity-oriented catalog that includes NAD+, glutathione, and GHK-Cu. It lists NAD+ at $69.99. A focused catalog can be a positive signal, since it suggests specialization in this category rather than a sprawling inventory.

CertaPeptides serves the European Union and offers NAD+ across several vial sizes, which is useful for research that requires different quantities. Its published pricing is 35.99 EUR for 100 mg, 59.99 EUR for 250 mg, 101.99 EUR for 500 mg, and 160.99 EUR for 1000 mg. As with any vendor, confirm the current price and COA on the supplier's own site before ordering, since inventory and pricing change.

When comparing vendors, weigh more than the sticker price. A slightly higher cost from a supplier that publishes independent lab results is usually the better value than a cheaper vial with no documentation. Also confirm that the vendor legally ships to your jurisdiction; a supplier that ships to your country is not automatically compliant with your local rules.

Practical checklist before you buy from any source: confirm the compound and mass match what you need, request the batch-specific COA if it is not published, verify the shipping region, and check that storage and handling guidance is provided. If you are also researching related compounds, our guide to how research compounds are combined and tracked covers documentation habits that carry over well to NAD+.

Finally, remember that no reputable vendor will make disease claims about NAD+. A seller promising that NAD+ will "reverse aging" or "cure" any condition is signaling that it prioritizes marketing over scientific accuracy, which should lower your trust in everything else it states.

One of the most common points of confusion is the difference between NAD+ itself and its precursors, chiefly NMN (nicotinamide mononucleotide) and NR (nicotinamide riboside). All three are connected through the NAD+ biosynthesis pathway, but they are handled very differently.

Research-grade NAD+ is usually supplied as a lyophilized powder for reconstitution and studied via injection in research settings, because the intact NAD+ molecule is large, charged, and poorly absorbed when taken orally. In contrast, NMN and NR are precursors that the body enzymatically converts into NAD+ after absorption. They are the molecules most often studied in oral human trials precisely because they survive digestion better than NAD+ itself.

The precursor approach has a logic: rather than delivering the finished coenzyme, you supply a building block and let the cell's own salvage pathway assemble NAD+ on demand. NR is converted to NMN, and NMN is then converted to NAD+. This is why much of the published human research on "NAD+ boosting" is actually research on NR or NMN rather than on NAD+ administered directly.

The table below summarizes the practical distinctions.

For a buyer, the takeaway is to be clear about which molecule you are actually purchasing. "NAD+" on a research vendor site generally means the injectable research compound, whereas NMN and NR are more often sold as oral research materials. They are not interchangeable, and evidence for one does not automatically transfer to the others. None of the three is approved as a treatment, and this article does not provide dosing guidance for any of them.

The scientific case for NAD+ in aging rests on a well-supported foundation and a still-open frontier. The foundation is that NAD+ is genuinely central to cellular function and that its levels fall with age; the frontier is whether restoring it produces meaningful benefits in humans.

Preclinical studies have shown that raising NAD+ or its precursors in aged animals can improve markers of mitochondrial function, support DNA repair activity, and enhance the function of sirtuin enzymes. In model organisms, NAD+ restoration has been associated with improvements in metabolic and tissue health parameters. These findings are what drove the intense research interest, and they are summarized in major reviews of NAD+ metabolism and aging.

Human evidence is more measured. Trials in people have largely used precursors such as NR and NMN rather than NAD+ directly. Some of these studies report that supplementation reliably raises blood NAD+ levels and is generally well tolerated over the periods studied, but robust clinical endpoints, such as demonstrated slowing of aging or prevention of age-related disease, have not been established. Increasing a biomarker is not the same as improving health outcomes.

This gap between mechanism and outcome is the honest center of the NAD+ story. The biology is compelling and the safety signal from precursor trials has so far been reassuring, but the leap from "NAD+ declines with age and is important" to "boosting NAD+ extends healthy lifespan in humans" is not yet supported by large, long-term controlled trials. Serious researchers treat NAD+ as a promising area of investigation rather than a settled intervention.

Medical disclaimer: This section describes research findings for educational purposes only. It is not medical advice, and NAD+ is not an approved treatment for aging or any disease. Anyone considering NAD+ for any reason should consult a qualified healthcare professional first.

Understanding the regulatory picture is essential before purchasing, because it shapes what a vendor may legally offer and how the product must be labeled. In most markets, NAD+ sold through research suppliers is classified as a research compound, or "for research use only" material, and is not approved as a drug for treating, preventing, or diagnosing any condition.

In the United States, the Food and Drug Administration (FDA) has not approved injectable NAD+ as a therapeutic product, and the agency has taken action regarding certain compounded and marketed NAD+ preparations. In the European Union, no NAD+ product carries a European Medicines Agency (EMA) marketing authorization for anti-aging indications. This is why compliant vendors label the material for research use and avoid disease claims.

The oral precursors occupy a different regulatory niche. NR, for example, has been marketed as a dietary ingredient in some jurisdictions, while NMN's regulatory status has shifted and varies by country. The status of any given molecule can differ between the US, the EU, the UK, and elsewhere, and it can change over time, so buyers should verify the current rules in their own jurisdiction rather than assuming uniformity.

Practically, this means several things for a buyer. Legitimate suppliers will describe NAD+ as a research compound, will not promise medical benefits, and will restrict shipping to regions where distribution is lawful. A vendor that markets NAD+ as an approved anti-aging therapy is misrepresenting its regulatory status, which is both a legal and a trust problem.

For a fuller picture of how research-compound regulation works and the disclaimers that apply, see our medical disclaimer and regulatory notes. When in doubt, treat NAD+ as an unapproved research material and consult a healthcare professional before any use.

NAD+ is rarely discussed in isolation within the longevity research community. It is usually one member of a broader cluster of compounds that are each studied for a distinct cellular mechanism, and understanding those neighbors helps clarify what NAD+ does and does not address.

Epithalon (epitalon) is a synthetic tetrapeptide studied primarily for its proposed effects on telomerase activity and circadian regulation. Where NAD+ research centers on energy metabolism and enzymatic repair, epithalon research focuses on chromosomal and telomere-related mechanisms, making it a conceptually complementary rather than overlapping compound. You can read more in our epithalon research guide.

Glutathione is the body's principal endogenous antioxidant, central to neutralizing oxidative stress and supporting detoxification pathways. Because oxidative damage is one of the drivers of cellular aging that NAD+-dependent repair systems respond to, glutathione is often discussed alongside NAD+ as part of a redox-focused research picture. Our glutathione guide covers its mechanisms in detail, and notably some vendors such as AminoClub carry both NAD+ and glutathione.

GHK-Cu, the copper tripeptide, is studied for its effects on gene expression, tissue remodeling, and collagen synthesis, with research suggesting it can influence a large number of genes. It represents the tissue-regeneration angle of the longevity cluster, distinct from NAD+'s metabolic role. See our GHK-Cu guide for the underlying science.

The reason these compounds are grouped together is not that they do the same thing, but that they target different, arguably complementary, hallmarks of aging: energy metabolism and repair (NAD+), telomere and chromosomal maintenance (epithalon), oxidative balance (glutathione), and tissue remodeling (GHK-Cu). This framing is useful for research context, but it is not a recommendation to combine them. Each remains an unapproved research compound, and there is limited human data on any of them individually, let alone in combination. Educational purposes only, and a qualified healthcare professional should be consulted before considering any of these materials.